A Phase I Study of Two Different Doses of the Subcutaneous Administration of an Immunotherapeutic Vaccine, DPX-0907 in Advanced Stage Patients With Ovarian, Breast or Prostate Cancer.

Trial Profile

A Phase I Study of Two Different Doses of the Subcutaneous Administration of an Immunotherapeutic Vaccine, DPX-0907 in Advanced Stage Patients With Ovarian, Breast or Prostate Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Dec 2015

At a glance

  • Drugs DPX 0907 (Primary)
  • Indications Breast cancer; Ovarian cancer; Prostate cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Aug 2012 Results were published in the Journal of Translational Medicine, according to an Immunovaccine media release. Results were also reported in the media release.
    • 04 Jun 2012 Results have been presented at ASCO-2012 according to an Immunovaccine media release. Results were also summarised in the media release.
    • 29 May 2012 Further results will be reported at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting, according to an Immunovaccine media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top